Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Chinese researchers report Nek2 inhibitor for gastrointestinal cancer

Dec. 18, 2015

GBT-1118 improves hypoxia survival in mice

Dec. 17, 2015

CC-31244 shows potent anti-HCV activity

Dec. 17, 2015

Probody drug conjugate targeting CD166 shows promise for the treatment of cancer

Dec. 17, 2015

PI3Kgamma inhibitor BVD-723 shows activity in murine models of cancer

Dec. 17, 2015

BET inhibitor from Zenith Epigenetics shows efficacy in preclinical studies

Dec. 17, 2015

Carmot and Sunesis present PDK1 inhibitors

Dec. 17, 2015

Dong-A presents Mer tyrosine kinase inhibitors

Dec. 16, 2015

Eisai presents pharmacological profile of EP4 receptor antagonist E-7046

Dec. 16, 2015

Arginase-1/2 inhibitor causes immune-mediated antitumor response in preclinical models

Dec. 16, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...